+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneron Pharmaceuticals Inc - logo

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

Grass Pollen Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Grass Pollen Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 48 Pages
  • Global
From
Cervical Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Cervical Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Next Generation Drug Conjugates Market: Industry Trends and Global Forecasts, Till 2035 - Product Thumbnail Image

Next Generation Drug Conjugates Market: Industry Trends and Global Forecasts, Till 2035

  • Report
  • December 2025
  • 120 Pages
  • Global
From
Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Regional Outlook and Forecast, 2022 - 2028 - Product Thumbnail Image

Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Regional Outlook and Forecast, 2022 - 2028

  • Report
  • November 2022
  • 175 Pages
  • Global
From
Ophthalmic Pharmaceutical Drugs - Global Strategic Business Report - Product Thumbnail Image

Ophthalmic Pharmaceutical Drugs - Global Strategic Business Report

  • Report
  • May 2026
  • 272 Pages
  • Global
From
Rheumatoid Arthritis Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type - Product Thumbnail Image

Rheumatoid Arthritis Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • Report
  • February 2024
  • 91 Pages
  • Global
From
Cancer Biomarkers Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Biomarker, Type of Cancer and Key Geographical Regions - Product Thumbnail Image

Cancer Biomarkers Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Biomarker, Type of Cancer and Key Geographical Regions

  • Report
  • March 2025
  • 309 Pages
  • Global
From
Unresectable Hepatocellular Carcinoma Market Report 2026 - Product Thumbnail Image

Unresectable Hepatocellular Carcinoma Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Colorectal Cancer Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Colorectal Cancer Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 181 Pages
  • Global
From
Cardiovascular Collaboration and Licensing Deals 2016-2026 - Product Thumbnail Image

Cardiovascular Collaboration and Licensing Deals 2016-2026

  • Report
  • April 2026
  • 350 Pages
  • Global
From
Melanoma Therapeutics: Global Markets - Product Thumbnail Image

Melanoma Therapeutics: Global Markets

  • Report
  • November 2023
  • 131 Pages
  • Global
From
Macular Edema Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Macular Edema Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2023
  • 99 Pages
  • Global
From
Age Related Macular Degeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Age Related Macular Degeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 289 Pages
  • Global
From
Graves' Ophthalmopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Graves' Ophthalmopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 67 Pages
  • Global
From
Fallopian Tube Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Fallopian Tube Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Basal Cell Carcinoma Treatment Market - Global Forecast 2026-2032 - Product Thumbnail Image

Basal Cell Carcinoma Treatment Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 193 Pages
  • Global
From
ADC Contract Manufacturing Market (7th Edition): Distribution by Stage of Development, Process Component, Type of Payload, Antibody Isotype, Target Indication, Antibody Origin, Type of Linker, and Key Geographical Regions - Industry Trends and Forecast 2025-2035 - Product Thumbnail Image

ADC Contract Manufacturing Market (7th Edition): Distribution by Stage of Development, Process Component, Type of Payload, Antibody Isotype, Target Indication, Antibody Origin, Type of Linker, and Key Geographical Regions - Industry Trends and Forecast 2025-2035

  • Report
  • March 2026
  • 451 Pages
  • Global
From
Rare Autoinflammatory Diseases Drug Market - Global Forecast 2026-2032 - Product Thumbnail Image

Rare Autoinflammatory Diseases Drug Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 181 Pages
  • Global
From
Asia Pacific Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Asia Pacific Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • July 2023
  • 119 Pages
  • Asia Pacific
From
North America Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

North America Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • July 2023
  • 111 Pages
  • North America
From
Loading Indicator